Notably, Brown et al. [70] indicated that the growth of DLBCL is mediated by suppression of MHC class II expression and immune response signatures and activation of Wnt/β-catenin signaling induced by FOXP1 [71]. This evidence concerns the gene FOXP1 and diffuse large B-cell lymphoma.